Wis. Farm Bureau Federation: Adopts new dairy policies
Contact: Casey Langan, Director of Public Relations, 608-828-5711
MADISON – The Wisconsin Farm Bureau Federation has adopted a set of policies in hopes of improving the short and long-term market prices that dairy farmers face.
WFBF’s board of directors recently approved the recommendations of its 20-member Dairy Committee, made up of dairy farmers from...
Wisconsin Energy Conservation Corporation: Manager Suzanne Harmelink honored with National Weatherization Award
Media Contact:
Mark Treichel
Hoffman York
(414) 225-9554
mtreichel@hyc.com
MADISON, Wis. (September 3, 2009) - Wisconsin Energy Conservation Corporation (WECC), a national leader in the design and...
USDA: Agriculture Secretary Vilsack awards $4.7 Million for tribal college grants
Contact:
Jay Fletcher (202) 690-0498
WASHINGTON, Sept. 3, 2009 - Agriculture Secretary Tom Vilsack today announced that 22 tribal colleges in nine states have been selected to receive $4.7 million through the USDA Rural Development Tribal College Grant program.
"This funding will help tribal colleges make much-needed infrastructure improvements so they can continue to provide job opportunities for local residents and spur...
Applied Tech: Workshop – Reduce IT Costs Through Virtualization
Applied Tech Contact: Julie Vike
608.257.6051 x23 or vike@appliedtech.us
----
When: Thursday, October 15, 2009
Time: 8:00am to 11:30am
Where: Lussier Family Heritage Center
3101 Lake Farm Road – Madison, WI 53711
Keynote Speaker: Gene Kussmann of Hewlett-Packard
Breakfast will be provided. RSVP required. No cost to attend.
Event Details:
Understand the benefits and drawbacks of the different software and technology available for virtualization. This...
Quintessence Biosciences Inc.: Phase II SBIR grant will fund development of EVade™ Ribonucleases
Support for the next generation of drug candidates from Quintessence Biosciences, Inc.
Contact: Ralph Kauten
(608) 441-2951
ralphk@Quintbio.com
Quintessence Biosciences, Inc. today announced the receipt of a Phase 2 Small Business Innovation Research (SBIR )grant from the National Cancer Institute to support the development of next generation drugs based on the EVade™ Ribonuclease (RNase) technology. This new class of drugs works by...
